Polar Capital Holdings PLC Arcutis Biotherapeutics, Inc. Transaction History

Polar Capital Holdings PLC

$16.3 Billion
Q3 2024

A detailed history of Polar Capital Holdings PLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 6,884,372 shares of ARQT stock, worth $63.7 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

6,884,372

Previous 6,879,072 0.08%

Holding current value

$63.7 Million

Previous $64 Million 0.08%

% of portfolio

0.39%

Previous 0.39%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.32 - $11.0 $44,096 - $58,300	5,300 Added 0.08%	6,884,372 $64 Million
Q2 2024 Aug 14, 2024	SELL	$7.24 - $12.53 $49,594 - $85,830	-6,850 Reduced 0.1%	6,879,072 $64 Million
Q1 2024 May 15, 2024	BUY	$3.25 - $11.77 $1.91 Million - $6.92 Million	588,234 Added 9.34%	6,885,922 $68.2 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $5.85 Million - $15.3 Million	3,179,744 Added 101.98%	6,297,688 $20.3 Million
Q3 2023 Nov 14, 2023	SELL	$5.31 - $10.98 $52,213 - $107,966	-9,833 Reduced 0.31%	3,117,944 $16.6 Million
Q2 2023 Dec 13, 2023	SELL	$7.51 - $15.0 $58,097 - $116,040	-7,736 Reduced 0.25%	3,127,777 $29.8 Million
Q2 2023 Aug 14, 2023	SELL	$7.51 - $15.0 $58,097 - $116,040	-7,736 Reduced 0.25%	3,127,777 $29.8 Million
Q1 2023 Dec 13, 2023	BUY	$10.23 - $17.14 $179,730 - $301,132	17,569 Added 0.56%	3,135,513 $34.5 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $11.6 Million - $19.4 Million	1,129,736 Added 56.32%	3,135,513 $34.5 Million
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $9.72 Million - $14.2 Million	696,509 Added 53.2%	2,005,777 $29.7 Million
Q3 2022 Nov 14, 2022	SELL	$17.85 - $26.95 $1.72 Million - $2.6 Million	-96,528 Reduced 6.87%	1,309,268 $25 Million
Q2 2022 Aug 15, 2022	SELL	$16.33 - $22.2 $6.18 Million - $8.4 Million	-378,209 Reduced 21.2%	1,405,796 $30 Million
Q4 2021 Feb 14, 2022	BUY	$14.98 - $25.5 $3.52 Million - $6 Million	235,104 Added 15.18%	1,784,005 $37 Million
Q3 2021 Nov 15, 2021	SELL	$19.28 - $27.1 $2.58 Million - $3.62 Million	-133,642 Reduced 7.94%	1,548,901 $37 Million
Q2 2021 Aug 16, 2021	BUY	$24.42 - $34.75 $3.05 Million - $4.34 Million	125,000 Added 8.03%	1,682,543 $45.9 Million
Q1 2021 May 17, 2021	BUY	$24.47 - $36.98 $19.1 Million - $28.9 Million	782,543 Added 100.97%	1,557,543 $45.1 Million
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $13.8 Million - $24.6 Million	775,000 New	775,000 $21.8 Million

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Arcutis Biotherapeutics, Inc. Transaction History